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We describe the isolation and characterization of a cDNA clone, called cCLP-1, that is a candidate for the previously
described early cardiac-specific transcription factor BBF-1. BBF-1 binds the MEF2 (or element B) binding site within the
cardiac myosin light chain 2 (MLC2) gene promoter. We used the element B sequence as a probe to screen an expression
library constructed from mRNA obtained from the presumptive heart-forming regions of stage 6 chicken embryos. This
yielded the cCLP-1 cDNA clone. Gel-shift analysis of stage 6 embryonic chicken protein extracts suggests that a protein that
is recognized by the anti-cCLP-1 antibody binds to the same element B binding site to which BBF-1 binds. cCLP-1 mRNA
was detected early in chicken development, prior to cardiac fate assignment at stage 4. The expression pattern of cCLP-1,
based on whole mount in situ hybridization, coincides remarkably well with the established morphogenetic field of early
heart formation. The nuclear localization of cCLP-1 is phosphorylation-dependent, suggesting that cCLP-1 may be a
member of that class of transcription factors whose activity is regulated by cytoplasm to nucleus transport. Taken together,
these data suggest that cCLP-1 may encode a novel transcription factor whose expression pattern is in agreement with that
of the cardiogenic precursor cells of the early chicken embryo. © 1999 Academic PressKey Words: cCLP-1; cardiac specification; cardiac development; cardiogenic lineage.
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The specification of distinct cell lineages in developing
embryos is believed to be determined by regionally re-
stricted lineage-specific transcription factors that influence
the expression pattern of downstream tissue-specific genes.
Cardiogenic cell lineage assignment is one of the first
functional specifications to occur during development (De-
Haan, 1965; Kessler and Melton, 1994; Antin et al., 1994).
In avian embryos, the cardiogenic precursor cells of meso-
dermal origin populate areas on either side of the anterior
primitive streak during gastrulation at stage 4 (Hamburger
and Hamilton, 1951). These cells migrate rostromedially
and coallesce to form the cardiac primordia which then
begins to express myofibrillar proteins leading to formation
of a functionally beating tubular heart at stage 10 (;33 h of
development) (Rosenquist and DeHaan, 1966). Cardiac cell
commitment itself is perceived as a progressive process
involving inductive signals originating from axial tissues,
the hypoblast, and subsequently from the anterior
210ndoderm (Rosenquist and DeHaan, 1966; Azar and Eyal-
iladi, 1979; Garcia-Martinez and Schoenwolf, 1993; Mont-
omery et al., 1994; Nascone and Marcola, 1995;
atskievych et al., 1997). Cells derived from stage 4, but not
tage 3, differentiate into myocytes, suggesting that cardiac
pecification occurs at stage 4, even though cardiogenic
rigin is traceable to the mesoderm of earlier stages (Mi-
awa et al., 1992; Linsak and Lash, 1993; Montgomery et
al., 1994). This would suggest that despite some level of
commitment of early mesodermal cells, a second inductive
state is required for cardiac differentiation. The complex
and progressive nature of the inductive interactions
whereby a mesodermal cell becomes committed to the
cardiac cell lineage is therefore likely to involve a number
of regulatory factors (Azar and Eyal-Giladi, 1979; Garcia-
Martinez and Schoenwolf, 1993; Montgomery et al., 1994).
The complex network of regulatory factors responsible
for the skeletal myogenic program has been relatively well
characterized, but the regulatory mechanisms underlying
cardiogenic development are poorly understood (see Olson
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211Regulation of Early Cardiogenesiset al., 1995; Mably and Liew, 1996; Goswami and Siddiqui,
1996, for review). Recently, several genes that are expressed
in either mesodermal precursors of cardiac myoblasts or in
differentiated cardiomyocytes have been identified and im-
plicated in the regulation of cardiac development. For
example, the murine homologs of the Drosophila tinman
gene, Nkx 2.5 (Lints et al., 1993) and Csx (Komuro and
Izumo, 1993), are essential for heart development (Bodmer,
1995; Azpiazu and Frasch, 1993) and play a role in the
differentiation of the vertebrate cardiac cell lineage (Lyons
et al., 1995a). The avian homolog of Nkx 2.5 (cNkx 2.5)
appears in cardiac progenitors as early as stage 5 (Schulthe-
iss et al., 1995), but is also present in the adult heart (Lyons
et al., 1995a). A novel subclass of bHLH proteins, called
dHAND and eHAND, identified in both avian (Srivastava et
l., 1995) and murine embryonic development (Hollenberg
t al., 1995; Cross et al., 1995), is expressed in various
developing tissues of ectodermal as well as mesodermal
origin and detected at stage 8 in chick development. These
genes also contribute to the formation of the adult heart and
its conduction system. Of the GATA family of transcrip-
tion factors, which are also candidate regulators of cardio-
genesis (Kelley et al., 1993; Jiang and Evans, 1996), GATA 4
is expressed in precardiogenic cells (Grepin et al., 1994) and
may play a role in the morphogenic folding of early cardiac
tissues (Kuo et al., 1997; Molkentin et al., 1997). The
myocyte enhancer factors, or MEF2 proteins, are members
of the MADS family of proteins and important regulators of
early cardiogenesis (Olson et al., 1995). During mouse
embryogenesis, MEF2 expression marks the cardiac and
skeletal as well as neuronal cell lineages (Edmondson et al.,
1994; Lyons et al., 1995). The fact that multiple isoforms of
MEF2 proteins exist which bind to functional DNA sites as
dimers points to their potential in executing diverse func-
tions in the regulation of gene transcription. A direct
interaction between MEF2 and MyoD proteins is evident in
activation of skeletal muscle gene expression (Molkentin et
al., 1995; Kaushal et al., 1994), suggesting that the interplay
between members of the MEF2 family and bHLH proteins
might be important for expression of skeletal muscle genes.
Such a cooperation between MEF2 family members and the
concomitantly expressed Nkx2.5/Csx homeobox genes has
been suggested as one mechanism that underlies the onset
of cardiogenic differentiation (Olson et al., 1995).
Despite the wealth of information on the cardiac regula-
tory factors described above, none of them were detected, at
least in avian embryos, in cardiac progenitor cells in stages
of development prior to cardiac fate assignment (stage 4), a
criterion in accord with the expected role of regulator(s) of
the cardiac cell lineage. We have previously reported that
the binding activity of a cardiac-specific transcription fac-
tor, BBF-1, which recognizes the MEF2 site in the cardiac
MLC-2 promoter (Zhou et al., 1993), appears in chicken
blastoderms as early as stage 4, prior to the onset of
cardiogenic gene expression (Goswami et al., 1994). The
early expression of BBF-1 and late expression of CMD-1, the
chicken homolog of MyoD (Lin et al., 1989), in avian
1
1
Copyright © 1999 by Academic Press. All rightdevelopment are consistent with the established patterns of
cardiac and skeletal morphogenetic development, respec-
tively, and provide a compelling argument in favor of the
role of BBF-1 in regulation of early cardiac development
(Goswami et al., 1994; Goswami and Siddiqui, 1996).
In this report, we describe the isolation and characteriza-
tion of a novel cDNA clone, pCLP-1 (cardiac lineage-
associated protein), a candidate clone for BBF-1 that is able
to bind the MEF2 or element B site within the cardiac
MLC2 gene promoter and whose early expression pattern in
chicken embryos coincides with the heart-forming cardio-
genic regions of the stage 4–6 chicken embryo.
MATERIALS AND METHODS
Isolation of cCLP-1 cDNA clone from stage 6 heart-forming
region cDNA library. Fresh fertilized White Leghorn eggs, pur-
chased from Spafas (Norwich CT), were incubated at 37.5°C and
allowed to develop to stage 6 (Hamburger and Hamilton, 1951).
Eggs were opened in Howard’s chick saline and the stage 6 embryos
identified under dissecting microscope were dissected to isolate
heart-forming region tissue. mRNA was isolated using the Micro-
fast Track kit (Invitrogen) and the cDNA library was custom-
constructed in the ZAP Express vector (Stratagene). Expression
screening of the library was carried out using an MLC2 promoter
element B (MEF2 site) hexamer as probe [(GACATGGGGT-
TATTTTTAGCCTGGAATGGG)6] (Goswami et al., 1994) in pro-
edures described by Singh et al. (1989). All subsequent molecular
iological procedures were carried out in accord with standard
ractices (Sambrook et al., 1987).
Gel mobility shift assays. Gel mobility shift assays were per-
ormed as described earlier (Zhou et al., 1993; Goswami et al.,
994). Double-stranded DNA fragments obtained by renaturation
f chemically synthesized oligonucleotides (GACATGGGGT-
ATTTTTAGCCTGGAATGGG) were radiolabeled at the 59 end
y polynucleotide kinase and [g-32P]ATP and used for the binding
assay. DNA probe (5,000 cpm) and nuclear proteins or cell extracts
were incubated in 10 mM Hepes (pH 7.9), 80 mM NaCl, 5 mM
MgCl2, 0.5 mM EDTA, 1 mM DTT, 12.5% glycerol at 4°C for 90
in and separated on a 6% polyacrylamide gel. For immunopre-
ipitation assays, anti-CLP-1 antiserum and anti-MEF2 antiserum
ere preincubated with cell extracts for 30 min at 4°C before
ddition of the DNA probe.
Northern and Western blot analysis. Total RNA was isolated
rom embryos of defined stages using RNAZol as per the manufac-
urer’s protocol (Tel Test Inc., Friendswood, TX). RNA (20 mg per
lane) was fractionated by formaldehyde agarose gel electrophoresis
and transferred onto nylon membranes by downward capillary
transfer in 203 SSC as per manufacturer’s instructions (Schleicher
and Schuell). cCLP-1 cDNA was radiolabeled to a high specific
activity (1.4 3 109 cpm/mg) and used for hybridization at 42°C for
16 h. After stringent washes (final wash: 33 in 0.13 SSC, 0.2%
DS, 60°C, 20 min) the filter was exposed to X-ray film. For
estern blot analysis of recombinant CLP-1 and proteins from
ther tissues, protein extracts were isolated by homogenization in
.1 M NaCl, 0.01 M Tris–Cl, pH 7.6, 0.001 M EDTA, 1 mg/ml
protinin, and 100 mg/ml PMSF. Proteins were fractionated by
2% SDS–PAGE and visualized by Western blotting (Towbin et al.,
979) using the CLP-1 antiserum and the ECL Western blot
s of reproduction in any form reserved.
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212 Ghatpande et al.developing reagent (Amersham) according to the manufacturer’s
protocol.
Whole mount in situ hybridization. Whole mount in situ
ybridization was performed according to Harland (1991) and
zpisua-Belmonte et al. (1993). Chick embryos were staged accord-
ing to Hamburger and Hamilton (1951) and fixed in MEMPHA (0.1
M Mops pH 7.4, 2 mM EDTA, 1 mM MgSO4 3.7% formaldehyde),
treated with 10 mg/ml proteinase K (Sigma) and postfixed in 4%
paraformaldehyde and 0.25% glutaraldehyde. Digoxigenin-labeled
sense and antisense riboprobes were prepared from the linearized
pCLP-1 DNA, 186-bp MLC2-specific subcloned PCR-amplified
DNA, and cNkx2.5 (kindly provided by T. Schultheiss) with T3 and
T7 RNA polymerase. Hybridization was carried out overnight at
70°C. After stringent washes (23 Solution I: 50% formamide, 53
SSC, pH 4.5, 1% SDS, 70°C for 30 min; 33 in Solution II: 0.5 M
aCl, 10 mM Tris–HCl, pH 7.5, 0.1% Tween 20 at 70°C for 10 min;
3 Solution II: 100 mg/ml RNase A for 30 min at 37°C; 23
olution III: 50% formamide, 23 SSC, pH 4.5, 60°C for 30 min)
mbryos were treated with Levamisole and 10% heat-inactivated
onspecific serum in TBST. Embryos were then incubated over-
ight in anti-digoxigenin alkaline phosphatase antibody and de-
ected by chromogenic reaction using NBT and BCIP. Embryos
ere washed in NTMT, postfixed in 4% formaldehyde and 0.1%
lutaraldehyde, dehydrated, and rehydrated to intensify pink to
urple color, cleared in glycerol/PBT, 1 mM EDTA, and stored in
his solution for photography and histological sectioning.
Cardiac cell culture and immunostaining. Primary cardiac
ells were prepared from 13- to 18-day-old embryonic chicken
earts essentially in accord with previously published procedures
Zadeh et al., 1986). Cells, cultured on chick serum and/or
bronectin-coated coverglasses, were allowed to grow for 24 h and
reated with 20 mM dibutyryl cAMP (Sigma) for various lengths of
ime. Upon completion of treatment, cells were fixed in methanol:
cetone (1:1) for 20 min at 220°C and air-dried. Cells were stained
sing MF20 (a monoclonal antibody directed against the myosin
eavy chain) and polyclonal anti-cCLP-1 antibodies with FITC and
RITC-tagged secondary antibodies, respectively. Cells were ob-
erved under epifluorescence using a Leitz Laborlux-S microscope
nd photographed.
RESULTS
Isolation of a cDNA clone for cardiac lineage-associated
protein. We have reported previously (Goswami et al.,
1994) that the first appearance of cardiac-specific gene
transcripts, e.g., cardiac MLC2 and a-actin, begins at the
head process stage (stage 5) in chicken development, imme-
diately after cardiac fate assignment at stage 4, whereas
skeletal muscle-specific mRNAs appear at stage 8 of devel-
opment soon after the formation of the first somite at stage
7. We have also shown that the mRNA for CMD-1, the
chicken homolog of MyoD, appears at stage 5, prior to
somite formation, consistent with its established role in
promoting the skeletal myogenic program. Based on these
observations, we based our cloning strategy on the likeli-
hood that gene product(s) involved in promoting the cardio-
genic program must be present at or prior to the stage in
which mesodermal cells are fated to become cardiogenic
(stage 4).
To isolate candidate cardiac lineage-specific gene(s), we
Copyright © 1999 by Academic Press. All rightttempted to construct a cDNA library from mRNA iso-
ated from the heart forming regions of stage 4 chicken
lastoderms. However, due to limitations in obtaining
ufficient amounts of mRNA from highly fragile stage 4
lastoderms, we resorted to microdissecting the well-
efined heart-forming regions of stage 6 embryos for isola-
ion of poly(A)1 RNA. A cDNA expression library was
ustom-constructed from this poly(A)1 RNA (Stratagene
nc.) and screened with a DNA probe consisting of a
ultimerized copy of the element B (MEF-2 site) present in
he chicken MLC-2 promoter (see Materials and Methods).
f the seven candidate cDNA clones obtained, one, cCLP-1,
ontained the largest insert of 1141 nucleotides. cCLP-1
as selected for further studies and subjected to sequence
nalysis. The nucleotide sequence along with the deduced
mino acid sequence which contains a contiguous polypep-
ide of 327 amino acids, is shown in Fig. 1. Northern blot
nalysis (see below) showed the size of cCLP-1 mRNA to be
bout 1300 bp, indicating that portions of 39 and 59 untrans-
ated regions are missing in the cCLP-1 cDNA. Two other
lasmids, pCLP-5 (;600 bp) and pCLP-7 (;721 bp) were also
equenced. pCLP-5 was ;30% homologus to pCLP-1 and
CLP-7 was identical in sequence to pCLP-1 with a 20-bp
xtension in the 39-end. The amino acid sequence of cCLP-1
erived from the nucleotide sequence did not reveal defined
inc finger or leucine zipper domains, although a basic
mino acid region (underlined), the putative DNA binding
omain, was located. Two sequence domains homologous
o the cAMP phosphorylation sites (italics) were also noted.
omparison of the cCLP-1 cDNA sequence in the GenBank
atabase indicated that cCLP-1 has no homology with
nown MEF2 sequences. However, when the cCLP-1 cDNA
equence was used to search the expressed sequence tagged
EST) database, significant sequence homology was found
etween cCLP-1 and an EST clone obtained from 19.5 dpc
ouse (W34238, 83% homology) and a human EST clone
N43814, 79% homology), indicating that cCLP-1-like tran-
cripts are also expressed in early mammalian develop-
ent.
Developmental expression of CLP-1 during early
hicken development. When total RNA from chicken
lastoderms of defined stages 1 through 20 was examined
y Northern blot hybridization, trace cCLP-1 signal was
etected as early as stage 1 and became more intense at
tage 3 onward with peak expression at stages 7–9 when
ardiac primordia undergo fusion (Fig. 2). The presence of a
CLP-1-positive signal at stages prior to cardiac fate assign-
ent (stage 4) is noteworthy and supports the notion that
he origin of cardiogenic cell precursors can be traced to the
esoderm of embryos earlier than stage 4 (Mikawa et al.,
992; Khaner, 1993; Linsak and Lash, 1993; Montgomery et
l., 1994).
The expression pattern of cCLP-1 mRNA was examined
y whole mount in situ hybridization using a digoxigenin-
labeled antisense cCLP-1 riboprobe. As shown in Fig. 3B,
cCLP-1 specific stain was present in the lateral plate region
in stage 4 embryos where cardiogenic progenitors are
s of reproduction in any form reserved.
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213Regulation of Early Cardiogenesisknown to be localized (Garcia-Martinez and Schoenwolf,
1993). Some stain was also localized in Hen-
sen’s node and the margins of the primitive streak from
which cardiac progenitors migrate to the lateral plate. The
sense riboprobe (Fig. 3A) served as negative control. As deve
lopment proceeds, cCLP-1 mRNA became concentrated in
the heart-forming regions of head process-stage embryos,
consistent with the established pattern of the movement of
cardiac progenitor cells in early cardiac development
(Rosenquist and DeHaan, 1966). cCLP-1 transcripts were
highly expressed in the anteromedial part of the cardiogenic
plate at the head fold level (Fig. 3D). At stage 11 (Fig. 3E),
cCLP-1-positive stain was present predominantly in the
heart, although some stain appeared in brain and neural
tube. Examination of subsequent stages revealed that cCLP-
1-positive stain begins to appear in noncardiac tissues,
especially in the brain. The presence of cCLP-1 in the
neurogenic area is not unexpected because several early
pattern-forming genes have been shown to have common
cardiogenic and neurogenic origins (see Discussion; see also
Landolph and Konicezny, 1995; Buffinger and Stockdale,
1995).
Transverse sectioning of stage 4 embryos subjected to
whole mount in situ hybridization with the cCLP-1 anti-
FIG. 1. Nucleotide sequence analysis of cCLP-1 cDNA. The pCLP
sequence was deduced and compared for homology using the DNA
shown with the amino terminal end at top right and the carboxy end
amino acid region are indicated by italics and underline, respectivense riboprobe shows increased cCLP-1 expression in the
ateral plate mesoderm (lpm, double arrowheads) from
Copyright © 1999 by Academic Press. All rightFIG. 2. Northern blot analysis. Total RNA from defined stages of
chicken embryos was isolated and fractionated on 1.4% formalde-
hyde agarose gel with appropriate RNA molecular weight markers.
Radiolabeled cCLP-1 cDNA (1.4 3 109 cpm/mg) was used to
hybridize the RNA as described under Materials and Methods.
b-actin cDNA probe was used as a control to normalize for-1 DNA sequencing was carried out as described in text. The amino acid
STAR program. The largest open reading frame of 327 amino acids isvariability in sample RNA loading (bottom). RNA size markers are
indicated on the left.
s of reproduction in any form reserved.
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215Regulation of Early Cardiogenesiswhich cardiac progenitors are derived (Fig. 3F). While some
stain was seen in intermediate mesoderm, axial and
paraxial mesoderm (pam) which give rise to notochord and
somites, respectively, were free of stain (area between thick
arrows). The low level of stain in ectodermal (ect) and
endodermal (end) cells may represent either background
stain or a low level of cCLP-1 in these cells at early stages
of development. Cross sections of stage 11 embryos hybrid-
ized with the cCLP-1 riboprobe (Fig. 3G) showed that
cCLP-1 expression was primarily localized in the heart with
some expression in the splanchnic mesodermal cells (sp)
from which precardiac myocytes originate and in the soma-
toplure (Sm) as well as where uncommitted myogenic cells
reside. No expression was apparent in the notochord, primi-
tive gut, and pharyngeal cells. These expression patterns
suggest that CLP-1 is expressed in those regions of early-
stage chicken embryos that are actively undergoing cardio-
genesis, but as development proceeds cCLP-1 does not
appear to be restricted to cardiac tissues alone.
Gel mobility shift analysis of chicken embryonic stage 6
extracts. To further examine the properties of cCLP-1, the
DNA was cloned into the pET-29 (1) S-tag expression
vector (Novagen, Inc.). This creates a fusion protein be-
tween cCLP-1 and an S-tag peptide that allows for purifica-
tion of recombinant cCLP-1 using S-tag-S-protein affinity
chromatography. Bacterially produced cCLP-1-S-tag fusion
protein was affinity purified according to instructions of the
supplier (Novagen, Inc.) and the purified recombinant
cCLP-1 protein was used as an immunogen for generation of
a rabbit polyclonal antiserum. The anti-cClp-1 antiserum
was tested by Western blot analysis using protein lysates of
12-day chicken embryonic heart, skeletal muscle, and liver
tissues. The antibody showed a positive reaction with a
protein in heart lysate (H) (Fig. 4A). No reactivity with
skeletal muscle (M) or liver (L) protein lysates could be
detected. The preimmune serum (PIS) served as negative
control. Upon prolonged exposure of these immunoblots to
film, a positive signal was evident in both skeletal muscle
and liver (data not shown). This finding parallels those of
our in situ hybridization studies on whole mount embryos
(see above) and suggests that low levels of cCLP-1 or a
CLP-1-like protein may be expressed in noncardiac tissues
in late embryonic development.
To examine whether stage 6 chicken embryos express
cCLP-1 protein and whether this protein can bind the
element B of the cardiac MLC2 promoter, we performed gel
mobility shift analyses of protein extracts taken from stage
6 embryos (Fig. 4B). Incubation of protein extracts with the
element B probe formed several complexes including one
complex that migrated with a mobility similar to that of a
complex formed by BBF-1 (Goswami et al., 1994). To
determine whether this complex contained cCLP-1 protein,
protein extracts from stage 6 embryos were preincubated
with the anti-cCLP-1 antiserum and used in parallel gel
shift assays with element B DNA (MEF-2 site) as probe.
This resulted in the disappearance of the BBF-1 complex
along with a partial supershift. The faster migrating com-
Copyright © 1999 by Academic Press. All rightlexes, BBF-2 and BBF-3, were unaffected by the antibody
reatment (Fig. 4B). The embryonic stage 6 extracts, as
hown previously, do not contain the slower migrating
EF-2 activity, which appears at later stages of develop-
ent (stages 8–9, Goswami et al., 1994). These results
FIG. 4. Tissue specificity of anti-cCLP-1 antibody (A). Recombi-
nant cCLP-1 protein and 12-day embryo protein extracts from
heart, skeletal muscle, and liver were analyzed by reaction with
anti-cCLP-1 antibody (left) and preimmune serum (right). H, heart;
M, skeletal muscle; L, liver; cCLP-1 Ab, anti-cCLP-1 antibody; PIS,
preimmune serum. Gel mobility shift assay with anti-cCLP anti-
body (B). Total protein extracts from stage 6 embryos were prein-
cubated with the antibody prior to gel shift assay with element B
DNA as described under Materials and Methods. BBF-1 complex
which has a mobility similar to that of the BBF-1 complex was
selectively disrupted (arrow) without affecting the fast moving
complexes, while the preimmune serum (PIS) was ineffective.demonstrate that CLP-1 is a BBF-1-like DNA binding factor
that is distinct from MEF2.
s of reproduction in any form reserved.
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216 Ghatpande et al.Cytoplasmic cCLP-1 is relocated into the nucleus. To
etermine if cardiomyocytes express cCLP-1, cardiomyo-
ytes isolated from 13-day-old embryonic hearts were cul-
ured in vitro and immunostained with anti-cCLP-1 anti-
erum. A strong cCLP-1-positive stain was detected in the
ultured cardiomyocytes (Fig. 5A). Cardiomyocytes were
dentified by counterstaining with antibody to myosin
eavy chain (MF20, a kind gift of D. Bader) (Fig. 5B.) The
CLP-1-positive immunostain was found in both the cyto-
lasm and the nucleus of cardiomyocytes (Fig. 5C), whereas
he myosin-positive stain was restricted to the cytoplasm as
xpected. It is well established that some regulatory pro-
eins, including a few transcription factors, are cytoplasmi-
ally localized and their import to the nucleus occurs in
esponse to developmental signals (Vanderomme et al.,
1996). Nuclear transport is known to involve phosphoryla-
tion at the casein kinase II (CK II) target site, but other
kinases, such as the cAMP-dependent protein kinase (PKA),
are also involved. Since cAMP is a known to be involved in
cardiac development in early embryos (Deshpande and
Siddiqui, 1976) and cAMP phosphorylation sites are present
in cCLP-1, we tested the possibility that addition of dibu-
tyryl cAMP to the culture medium would promote trans-
port of cCLP-1 to the nucleus. Cardiac myocytes obtained
from chicken embryonic heart were cultured in the pres-
ence of dibutyryl cAMP (20 mM) and the distribution of the
cCLP-1 protein was examined by immunological detection
as outlined above. As shown in Fig. 6A, the cCLP-1-positive
stain was distributed in both the cytoplasm and nucleus,
but upon treatment of cardiomyocytes in culture with
FIG. 5. CLP-1 is a cardiac myocyte-specific protein. Cultured c
neously stained with polyclonal anti-cCLP-1 antibody (A) and M
Phase-contrast photograph of the same field is shown in C. Cardioc
negative with both antibodies.dibutyryl cAMP for 12 h, there was a dramatic import of
cCLP-1 into nuclei (Fig. 6B). This suggests that cytoplasmic
Copyright © 1999 by Academic Press. All rightCLP-1 is functionally transported to the nuclei, perhaps
ollowing its phosphorylation (Vanderomme et al., 1996).
DISCUSSION
Recently, several novel transcription factors have been
identified that are expressed in cardiogenic mesodermal
cells or in response to the inductive events leading to
formation of cardiac muscle. Among these factors are the
homeobox protein cNkx2.5 (Schultheiss et al., 1995), the
GATA proteins (Laverriere et al., 1994; Grepin et al., 1994),
a subclass of bHLH motif proteins, dHAND and eHAND
(Srivastava et al., 1995), MEF2C (Edmondson et al., 1994),
and a novel protein, CMF1, that is immunologically related
to bHLH family members (Wei et al., 1996). cNkx2.5,
which shares homology with the tinman gene required for
Drosophila heart formation (Bodmer 1995; Harvey 1996), is
induced in avian posterior primitive streak cells by anterior
lateral endoderm, suggesting that cNkx2.5 is an early
marker of cardiogenesis and has a role in cardiac induction
(Schultheiss et al., 1995). Despite these findings, recent
evidence suggests that cNkx2.5 may function at later stages
of development. For example, in vivo expression of cNkx2.5
begins only at early head-process stages in chicken embry-
onic development and the null Nkx2.5 mutation in mouse
results in heart defects arising later in development than
would be expected if it was a functional homolog of the
Drosophila tinman gene, where the mutant phenotype
exhibits a complete absence of cardiogenic cells (Lyons et
c myocytes from 13-day embryonic chicken heart were simulta-
a monoclonal antibody directed against myosin heavy chain (B).
are positive for both anti-CLP-1 and MF20, whereas fibroblasts areardia
F20,al., 1995a). Other markers of early cardiogenesis such as
GATA-4 (Kelley et al., 1993; Kuo et al., 1997; Molkentin et
s of reproduction in any form reserved.
217Regulation of Early CardiogenesisFIG. 6. Nuclear translocation of cCLP-1. (A) CLP-1-positive immunofluorescence distributed in both the cytoplasm and nucleus of 13-day
embryonic cardiomyocytes is shown in right and the phase-contrast photograph of the same field in left. (B) After 12 h treatment of
cardiomyocytes in culture with 20 mM dibutyryl cAMP, cCLP-1-positive immunofluorescence was translocated into the nucleus (right).
Phase-contrast photograph of the same field is shown in left.
Copyright © 1999 by Academic Press. All rights of reproduction in any form reserved.
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218 Ghatpande et al.al., 1997), MEF-2C, (Edmondson et al., 1994; Lin et al.,
1997), dHAND and eHAND (Srivastava et al., 1995; 1997),
and pCMF1 (Wei et al., 1996) all appear to have an expres-
sion pattern that begins only in the postcommitment period
of cardiac development (Fig. 7).
In this report, we describe the isolation and preliminary
characterization of a cDNA clone, cCLP-1, that is a candi-
date for a cardiogenic factor involved in the expression of
cardiac-specific genes. Several features of cCLP-1 suggest
that it may be involved in the early stages of cardiogenesis,
perhaps as a transcription factor either directly on indi-
rectly affecting the expression of cardiogenic genes. First,
the cDNA library expression screening procedure that
yielded the cCLP-1 cDNA clone was designed to isolate
cardiogenic transcription factors; the probe used consisted
of a known myogenic DNA binding site, the MEF2 or B
element binding site from the cardiac MLC2 gene promoter,
and the cDNA library screened was derived from the early
heart-forming region of stage 6 chicken embryos. Together,
these two parameters should strongly bias potential posi-
tive clones to the cardiogenic class of transcription factors.
Second, both Northern blot and in situ hybridization data
suggest that the early expression of cCLP-1 in stage 4
FIG. 7. Temporal expression of genes potentially involved in the
beginning with stage 1 through 12 (Hamburger and Hamilton, 1951
polymerase chain reaction (PCR) and by in situ hybridization (ISH
et al., 1994; (2) Schultheiss et al., 1995; (3) Laverriere et al., 1994; (chicken embryos onward is preferentially enriched in re-
gions of the embryo undergoing cardiogenesis. Northern
Copyright © 1999 by Academic Press. All rightblot analysis shows that cCLP-1 is expressed during the
earliest stages of chicken embryonic development with
peak expression occurring during heart tube fusion stages
(around stages 7–9). In situ hybridization studies localized
cCLP-1 expression to cardiogenic regions of the embryo,
such as the anteromedial region, and also indicated expres-
sion in areas from which migratory cardiogenic precursor
cells arise such as the margins of the primitive streak.
Together, these data provide evidence for the expression of
cCLP-1 in cells derived from regions of the embryo from
which cardiogenic precursors arise both prior to and during
periods of active cardiogenesis.
Third, gel-shift analysis using protein extracts of stage 6
chicken embryos shows that cCLP-1 binds the MEF2 bind-
ing site (element B) of the cardiac MLC2 gene promoter
(confirming our expression screening protocol that origi-
nally yielded the cCLP-1 cDNA clone). In similar gel-shift
analyses of nuclear extracts of cardiomyocytes, typically
three predominant complexes are formed: BBF-1, BBF-2, and
BBF-3. Using specific cCLP-1 antibody to disrupt formation
of putative cCLP-1–element B complexes led to the specific
ablation of the BBF-1 complex, suggesting that cCLP-1 in
stage 6 chicken embryos is mediating BBF-1 binding activ-
lation of early avian cardiogenesis. Chicken developmental stages
shown from left to right within the box. Gene products assayed by
shown in sequence on top and bottom, respectively. (1) Goswami
oissant et al., 1996; (5) Srivastava et al., 1995; (6) Wei et al., 1996.regu
) are
) areity.
Fourth, cCLP-1 protein can be detected in cultured cardi-
s of reproduction in any form reserved.
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219Regulation of Early Cardiogenesisomyocytes by immunohistochemistry using the specific
anti-cCLP-1 antiserum which we generated against recom-
binant cCLP-1. This provides further evidence that the
cCLP-1 cDNA clone derived from the stage 6 heart-forming
region cDNA library encodes a bonafide cardiac protein
detectable in cardiomyocytes isolated from embryonic
heart. Interestingly, the cellular localization of cCLP-1
appears to be controllable; phosphorylation of cCLP-1
stimulates the transport of cCLP-1 from the cytoplasm to
the nucleus. This is similar to a number of transcription
factors whose nuclear localization is also phosphorylation
state-dependent, raising the possibility that cCLP-1 may
also be a transcription factor whose activity is likewise
dependent on phosphorylation state and cellular localiza-
tion.
Taken together, these data provide evidence that the
cCLP-1 cDNA clone that we have isolated is a novel protein
expressed in the earliest cardiogenic precursor cells of the
chicken embryo. cCLP-1 can bind an important regulatory
element found in the promoter of the cardiac MLC2 gene,
suggesting that it is an important component of the tran-
scriptional machinery required for MLC2 gene transcrip-
tion. The expression of cCLP-1 in cardiogenic precursor
cells raises the possibility that the transcriptional proper-
ties of cCLP-1 may not be limited to myofibrillar proteins
such as cMLC2 that are expressed late in the cardiogenic
program, but may also be directed to early cardiogenic genes
as well. We are presently addressing this possibility experi-
mentally by assessing the effects of antisense ablation of
cCLP-1 mRNA on early cardiogenic genes such as cNkx2.5
and structural genes such as vMLC2. Preliminary results
show that cNkx2.5 and vMLC2 mRNAs are absent in
chicken embryos treated with antisense cCLP-1 oligonucle-
otides (unpublished observations).
While cCLP-1-positive staining is restricted predomi-
nantly to cardiogenic regions of the chicken embryo, a
broader expression pattern was evident in later stages of
development with cCLP-1 expression found in the noto-
chord, brain, and neural fold areas (data not shown). This is
not inconsistent with the expression patterns of other
candidate cardiogenic regulators. For instance, transcripts
of cNkx2.5 also appear in other tissues in late development,
such as foregut and pharyngeal regions (Schultheiss et al.,
1995). The MEF-2 family proteins have also been shown to
play a role in differentiation of both cardiac and nervous
systems (Edmondson et al., 1994; Lyons et al., 1995; Lin et
l., 1997). Likewise, the chicken regulatory protein,
AP3000, is expressed during early development of the
eart but is also associated with differentiation of the
eural crest cells as well (McCabe et al., 1995). The chicken
eurogenic gene, c-serrate-1, is expressed in both central
ervous system and the heart (Myat et al., 1996) and its
ounterpart in rat, jagged, inhibits differentiation of cul-
ured myoblasts by down-regulation of myogenin gene
xpression (Lindsell et al., 1995). It appears that the neuro-
enic cells of early embryos sequester molecules important
Copyright © 1999 by Academic Press. All rightor cardiac differentiation (Climent et al., 1995; see Lan-
olph and Konieczny, 1995, for review).
Based on the available evidence, cCLP-1 has properties
ndicative of a transcription factor involved in both early
nd late cardiogenic gene expression. We are presently
esting the possibility that cCLP-1 is a bonafide transcrip-
ion factor by assessing the ability of cCLP-1 to transacti-
ate reporter genes under the control of MEF2 (or element
) gene promoter elements. Given our current understand-
ng that some transcription factors cooperate with other
actors to fully activate transcription, it is likely that
CLP-1 will also require similar interactions to activate
ranscription of cardiac genes. Evidence for this occurring in
arly cardiac gene expression already exists. For example,
ooperation between MEF-2 and Nkx family members
Olson et al., 1995) and Nkx and SRF (serum response
actor) transcription factors appears necessary for cardiac
yogenesis (Croissant et al., 1996). It is noteworthy that we
ave been able to locate, using MEF-2-specific gene primers,
EF-2 transcripts as early as stage 2/3 of chicken develop-
ent (Goswami et al., 1994). Yet, the DNA binding activity
f at least one complex bound to the MEF-2 site with slow
obility, characteristic of MEF-2s in several species, ap-
ears only late at stage 8, while other complexes, including
BF-1, appear as early as stage 4 of development, indicating
hat MEF-2 and BBF-1/cCLP-1 are functionally distinct
Goswami et al., 1994). Since multiple members of regula-
ory protein families have been implicated in cardiac speci-
cation, some perhaps with overlapping functions, a com-
inatorial role for cCLP-1 in partnership with other factors,
uch as Nkx family members, is not inconceivable. Further
haracterization of cCLP-1 based on genetic manipulation
f cCLP-1 in other vertebrates, presently in progress in our
aboratory, will be required to fully understand the regula-
ory cross-talk between transcription factors which control
arly heart development.
Note added in proof. A recent search of the Genbank database
sequences showed that a portion of cCLP-1 has significant (. 90%)
homology with the human vascular smooth muscle inducible
protein (HIS1) sequence, but in the codon reading frame other than
shown in Fig. 1 above.
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